Christophe P. Nicot - Publications

Affiliations: 
Microbiology, Molecular Genetics & Immunology University of Kansas, Lawrence, KS, United States 
Area:
Microbiology Biology, Virology Biology

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Bellon M, Nicot C. HTLV-1 Tax Tug-of-War: Cellular Senescence and Death or Cellular Transformation. Pathogens (Basel, Switzerland). 13. PMID 38276160 DOI: 10.3390/pathogens13010087  0.81
2023 Bellon M, Nicot C. Targeting Pim kinases in hematological cancers: molecular and clinical review. Molecular Cancer. 22: 18. PMID 36694243 DOI: 10.1186/s12943-023-01721-1  0.685
2022 Bellon M, Nicot C. FHIT as a biomarker for early screening of adult T-cell leukemia. Journal of Cancer Biology. 2: 71-74. PMID 35663592 DOI: 10.46439/cancerbiology.2.028  0.764
2022 Fan J, Bellon M, Ju M, Zhao L, Wei M, Fu L, Nicot C. Clinical significance of FBXW7 loss of function in human cancers. Molecular Cancer. 21: 87. PMID 35346215 DOI: 10.1186/s12943-022-01548-2  0.749
2021 Bellon M, Nicot C. Feedback Loop Regulation between Pim Kinases and Tax Keeps Human T-Cell Leukemia Virus Type 1 Viral Replication in Check. Journal of Virology. 96: e0196021. PMID 34818069 DOI: 10.1128/JVI.01960-21  0.809
2021 Bellon M, Bialuk I, Galli V, Bai XT, Farre L, Bittencourt A, Marçais A, Petrus MN, Ratner L, Waldmann TA, Asnafi V, Gessain A, Matsuoka M, Franchini G, Hermine O, ... ... Nicot C, et al. Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases. Molecular Cancer. 20: 86. PMID 34092254 DOI: 10.1186/s12943-021-01370-2  0.778
2020 Yeh CH, Bellon M, Wang F, Zhang H, Fu L, Nicot C. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells. Molecular Cancer. 19: 139. PMID 32907612 DOI: 10.1186/S12943-020-01254-X  0.789
2020 Bellon M, Nicot C. Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia. International Journal of Cancer and Oncology. 2. PMID 26430700 DOI: 10.15436/2377-0902.15.017  0.806
2018 Bellon M, Moles R, Chaib-Mezrag H, Pancewicz J, Nicot C. JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells. Journal of Hematology & Oncology. 11: 119-119. PMID 30231940 DOI: 10.1186/S13045-018-0665-6  0.766
2018 Yeh CH, Bellon M, Nicot C. FBXW7: a critical tumor suppressor of human cancers. Molecular Cancer. 17: 115. PMID 30086763 DOI: 10.1186/S12943-018-0857-2  0.731
2017 Bellon M, Nicot C. Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection Viruses. 9: 289. PMID 28981470 DOI: 10.3390/V9100289  0.799
2017 Bai XT, Yeh CH, Nicot C. NOTCH1 Activation Depletes the Pool of Side Population Stem Cells in ATL. Journal of Cancer Sciences. 4. PMID 28920078  0.387
2016 Moles R, Bai XT, Chaib-Mezrag H, Nicot C. WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells. Journal of Hematology & Oncology. 9: 121. PMID 27829440 DOI: 10.1186/S13045-016-0352-4  0.565
2016 Yeh CH, Bellon M, Pancewicz-Wojtkiewicz J, Nicot C. Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 27247421 DOI: 10.1073/Pnas.1601537113  0.792
2016 Yeh CH, Moles R, Nicot C. Clinical significance of microRNAs in chronic and acute human leukemia. Molecular Cancer. 15: 37. PMID 27179712 DOI: 10.1186/S12943-016-0518-2  0.337
2016 Yeh CH, Bai XT, Moles R, Ratner L, Waldmann TA, Watanabe T, Nicot C. Erratum to: 'Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia'. Molecular Cancer. 15: 20. PMID 26936184 DOI: 10.1186/S12943-016-0504-8  0.467
2016 Yeh CH, Bai XT, Moles R, Ratner L, Waldmann TA, Toshiki W, Nicot C. Mutation of epigenetic regulators TET2 and MLL3 in patients with HTLV-I-induced acute adult T-cell leukemia. Molecular Cancer. 15: 15. PMID 26880370 DOI: 10.1186/S12943-016-0500-Z  0.447
2016 Bellon M, Lu L, Nicot C. Constitutive activation of Pim1 kinase is a therapeutic target for adult T-cell leukemia. Blood. PMID 26813676 DOI: 10.1182/Blood-2015-11-685032  0.804
2015 Nicot C. HTLV-I Tax-Mediated Inactivation of Cell Cycle Checkpoints and DNA Repair Pathways Contribute to Cellular Transformation: "A Random Mutagenesis Model". Journal of Cancer Sciences. 2. PMID 26835512 DOI: 10.13188/2377-9292.1000009  0.374
2015 Bai XT, Moles R, Chaib-Mezrag H, Nicot C. Small PARP inhibitor PJ-34 induces cell cycle arrest and apoptosis of adult T-cell leukemia cells. Journal of Hematology & Oncology. 8: 117. PMID 26497583 DOI: 10.1186/S13045-015-0217-2  0.513
2015 Moles R, Nicot C. The Emerging Role of miRNAs in HTLV-1 Infection and ATLL Pathogenesis Viruses. 7: 4047-4074. PMID 26205403 DOI: 10.3390/V7072805  0.441
2015 Nicot C. Tumor Suppressor Inactivation in the Pathogenesis of Adult T-Cell Leukemia Journal of Oncology. 2015: 183590-183590. PMID 26170835 DOI: 10.1155/2015/183590  0.595
2015 Moles R, Bellon M, Nicot C. STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I-Transformed and ATL Cells. Neoplasia. 17: 449-462. PMID 26025667 DOI: 10.1016/J.Neo.2015.04.005  0.762
2015 Bai XT, Nicot C. miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection. The Journal of Biological Chemistry. 290: 5381-90. PMID 25568327 DOI: 10.1074/Jbc.M114.626325  0.447
2014 Chaib-Mezrag H, Lemaçon D, Fontaine H, Bellon M, Bai XT, Drac M, Coquelle A, Nicot C. Tax impairs DNA replication forks and increases DNA breaks in specific oncogenic genome regions. Molecular Cancer. 13: 205. PMID 25185513 DOI: 10.1186/1476-4598-13-205  0.792
2013 Bellon M, Ko NL, Lee MJ, Yao Y, Waldmann TA, Trepel JB, Nicot C. Adult T-cell leukemia cells overexpress Wnt5a and promote osteoclast differentiation. Blood. 121: 5045-54. PMID 23660959 DOI: 10.1182/Blood-2012-07-439109  0.772
2013 Ko NL, Taylor JM, Bellon M, Bai XT, Shevtsov SP, Dundr M, Nicot C. PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency. Blood. 121: 791-800. PMID 23104922 DOI: 10.1182/Blood-2012-03-420414  0.804
2012 Bai XT, Nicot C. Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis Frontiers in Microbiology. 3: 400-400. PMID 23248621 DOI: 10.3389/Fmicb.2012.00400  0.497
2012 Baydoun HH, Bai XT, Shelton S, Nicot C. HTLV-I tax increases genetic instability by inducing DNA double strand breaks during DNA replication and switching repair to NHEJ. Plos One. 7. PMID 22916124 DOI: 10.1371/Journal.Pone.0042226  0.481
2012 Yao Y, Bellon M, Shelton SN, Nicot C. Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression Journal of Biological Chemistry. 287: 20737-20747. PMID 22496369 DOI: 10.1074/Jbc.M111.319236  0.734
2012 Bai XT, Sinha-Datta U, Ko NL, Bellon M, Nicot C. Nuclear export and expression of human T-cell leukemia virus type 1 tax/rex mRNA are RxRE/Rex dependent. Journal of Virology. 86: 4559-65. PMID 22318152 DOI: 10.1128/Jvi.06361-11  0.766
2011 Pancewicz J, Nicot C. Current views on the role of Notch signaling and the pathogenesis of human leukemia Bmc Cancer. 11: 502-502. PMID 22128846 DOI: 10.1186/1471-2407-11-502  0.444
2011 Andresen V, Pise-Masison CA, Sinha-Datta U, Bellon M, Valeri V, Parks RW, Cecchinato V, Fukumoto R, Nicot C, Franchini G. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles Blood. 118: 1549-1559. PMID 21677314 DOI: 10.1182/Blood-2010-06-293340  0.775
2011 Baydoun HH, Pancewicz J, Nicot C. Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA repair Blood. 117: 5897-5906. PMID 21427292 DOI: 10.1182/Blood-2010-08-304600  0.538
2011 Jones KS, Bertolette DC, Bai XT, Petrow-Sadowski C, Fu T, Franchini G, Nicot C, Ruscetti FW. Continuous long-term growth of plasmacytoid dendritic cells following in vitro infection with HTLV-1 Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A174  0.522
2011 Andresen V, Pise-Masison CA, Sinha-Datta U, Parks RW, Cecchinato V, Fukumoto R, Nicot C, Franchini G. Tax-mediated re-routing of the HTLV-1 p13 protein to nuclear speckles Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A125  0.473
2010 El Hajj H, El-Sabban M, Hasegawa H, Zaatari G, Ablain J, Saab ST, Janin A, Mahfouz R, Nasr R, Kfoury Y, Nicot C, Hermine O, Hall W, de Thé H, Bazarbachi A. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. The Journal of Experimental Medicine. 207: 2785-92. PMID 21135137 DOI: 10.1084/Jem.20101095  0.519
2010 Baydoun HH, Pancewicz J, Bai X, Nicot C. HTLV-I p30 inhibits multiple S phase entry checkpoints, decreases cyclin E-CDK2 interactions and delays cell cycle progression. Molecular Cancer. 9: 302. PMID 21092281 DOI: 10.1186/1476-4598-9-302  0.554
2010 Pancewicz J, Taylor JM, Datta A, Baydoun HH, Waldmann TA, Hermine O, Nicot C. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia. Proceedings of the National Academy of Sciences of the United States of America. 107: 16619-24. PMID 20823234 DOI: 10.1073/Pnas.1010722107  0.567
2010 Valeri VW, Hryniewicz A, Andresen V, Jones K, Fenizia C, Bialuk I, Chung HK, Fukumoto R, Parks RW, Ferrari MG, Nicot C, Cecchinato V, Ruscetti F, Franchini G. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood. 116: 3809-17. PMID 20647569 DOI: 10.1182/Blood-2010-05-284141  0.504
2010 Bai XT, Baydoun HH, Nicot C. HTLV-I p30: a versatile protein modulating virus replication and pathogenesis Molecular Aspects of Medicine. 31: 344-349. PMID 20595036 DOI: 10.1016/J.Mam.2010.05.004  0.379
2010 Bellon M, Baydoun HH, Yao Y, Nicot C. HTLV-I Tax-dependent and -independent events associated with immortalization of human primary T lymphocytes Blood. 115: 2441-2448. PMID 20093405 DOI: 10.1182/Blood-2009-08-241117  0.817
2009 Taylor JM, Brown M, Nejmeddine M, Kim KJ, Ratner L, Lairmore M, Nicot C. Novel role for interleukin-2 receptor-jak signaling in retrovirus transmission Journal of Virology. 83: 11467-11476. PMID 19726513 DOI: 10.1128/Jvi.00952-09  0.533
2009 Taylor JM, Ghorbel S, Nicot C. Genome wide analysis of human genes transcriptionally and post-transcriptionally regulated by the HTLV-I protein p30. Bmc Genomics. 10: 311-311. PMID 19602286 DOI: 10.1186/1471-2164-10-311  0.487
2009 Bellon M, Lepelletier Y, Hermine O, Nicot C. Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia Blood. 113: 4914-4917. PMID 19246560 DOI: 10.1182/Blood-2008-11-189845  0.731
2009 Baydoun HH, Bellon M, Nicot C. HTLV-1 Yin and Yang: Rex and p30 master regulators of viral mRNA trafficking. Aids Reviews. 10: 195-204. PMID 19092975  0.777
2009 Fukumoto R, Andresen V, Bialuk I, Cecchinato V, Walser JC, Valeri VW, Nauroth JM, Gessain A, Nicot C, Franchini G. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood. 113: 3726-34. PMID 18791162 DOI: 10.1182/Blood-2008-04-146928  0.511
2009 Bazarbachi A, Hajj HE, El-Sabban M, Hasegawa H, Zaatari G, Saab S, Janin A, Mahfouz R, Nasr R, Kfoury Y, Nicot C, Hermine O, Hall W. The Combination of Arsenic Trioxide and Interferon-Alpha Eradicates Leukemia Initiating Cells in TAX-Driven Murine Adult T Cell Leukemia/Lymphoma. Blood. 114: 2714-2714. DOI: 10.1182/Blood.V114.22.2714.2714  0.478
2008 Bellon M, Nicot C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells Blood. 112: 2946-2955. PMID 18511807 DOI: 10.1182/Blood-2008-01-134692  0.778
2008 Taylor JM, Nicot C. HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches. Apoptosis. 13: 733-747. PMID 18421579 DOI: 10.1007/S10495-008-0208-7  0.537
2008 Bellon M, Nicot C. Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control Journal of the National Cancer Institute. 100: 98-108. PMID 18182620 DOI: 10.1093/Jnci/Djm269  0.797
2008 Sinha-Datta U, Taylor JM, Brown M, Nicot C. Celecoxib disrupts the canonical apoptotic network in HTLV-I cells through activation of Bax and inhibition of PKB/Akt. Apoptosis. 13: 33-40. PMID 17952603 DOI: 10.1007/S10495-007-0148-7  0.515
2008 Datta A, Nicot C. Telomere attrition induces a DNA double-strand break damage signal that reactivates p53 transcription in HTLV-I leukemic cells. Oncogene. 27: 1135-1141. PMID 17704807 DOI: 10.1038/Sj.Onc.1210718  0.542
2007 Bellon M, Nicot C. Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia. Cancer Genomics & Proteomics. 4: 21-5. PMID 17726237  0.78
2007 Lacoste V, Nicot C, Gessain A, Valensi F, Gabarre J, Matta H, Chaudhary PM, Mahieux R. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle. British Journal of Haematology. 138: 487-501. PMID 17659053 DOI: 10.1111/J.1365-2141.2007.06697.X  0.441
2007 Fukumoto R, Dundr M, Nicot C, Adams A, Valeri VW, Samelson LE, Franchini G. Inhibition of T-Cell Receptor Signal Transduction and Viral Expression by the Linker for Activation of T Cells-Interacting p12I Protein of Human T-Cell Leukemia/Lymphoma Virus Type 1 Journal of Virology. 81: 9088-9099. PMID 17582004 DOI: 10.1128/Jvi.02703-06  0.577
2007 Sinha-Datta U, Datta A, Ghorbel S, Dodon MD, Nicot C. Human T-cell lymphotrophic virus type I rex and p30 interactions govern the switch between virus latency and replication. Journal of Biological Chemistry. 282: 14608-14615. PMID 17360706 DOI: 10.1074/Jbc.M611219200  0.509
2007 Brown M, Bellon M, Nicot C. Emodin and DHA potently increase arsenic trioxide interferon-α–induced cell death of HTLV-I–transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1 Blood. 109: 1653-1659. PMID 17077332 DOI: 10.1182/Blood-2006-04-015537  0.778
2006 Ghorbel S, Sinha-Datta U, Dundr M, Brown M, Franchini G, Nicot C. Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit Journal of Biological Chemistry. 281: 37150-37158. PMID 17008317 DOI: 10.1074/Jbc.M603981200  0.536
2006 Bellon M, Datta A, Brown M, Pouliquen J, Couppie P, Kazanji M, Nicot C. Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia. International Journal of Cancer. 119: 2090-2097. PMID 16786598 DOI: 10.1002/Ijc.22026  0.796
2006 Datta A, Sinha-Datta U, Dhillon NK, Buch S, Nicot C. The HTLV-I p30 interferes with TLR4 signaling and modulates the release of pro- and anti-inflammatory cytokines from human macrophages. The Journal of Biological Chemistry. 281: 23414-24. PMID 16785240 DOI: 10.1074/Jbc.M600684200  0.349
2006 Datta A, Bellon M, Sinha-Datta U, Bazarbachi A, Lepelletier Y, Canioni D, Waldmann TA, Hermine O, Nicot C. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood. 108: 1021-1029. PMID 16569765 DOI: 10.1182/Blood-2006-01-0067  0.806
2005 Nicot C, Harrod RL, Ciminale V, Franchini G. Human T-cell leukemia/lymphoma virus type 1 nonstructural genes and their functions. Oncogene. 24: 6026-34. PMID 16155609 DOI: 10.1038/Sj.Onc.1208977  0.514
2005 Nicot C. Current views in HTLV-I-associated adult T-cell leukemia/lymphoma. American Journal of Hematology. 78: 232-239. PMID 15726602 DOI: 10.1002/Ajh.20307  0.532
2004 Sinha-Datta U, Horikawa I, Michishita E, Datta A, Sigler-Nicot JC, Brown M, Kazanji M, Barrett JC, Nicot C. Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I-transformed cells Blood. 104: 2523-2531. PMID 15226182 DOI: 10.1182/Blood-2003-12-4251  0.549
2004 Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T, Franchini G. HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication. Nature Medicine. 10: 197-201. PMID 14730358 DOI: 10.1038/Nm984  0.552
2003 Franchini G, Nicot C, Johnson JM. Seizing of T cells by human T-cell leukemia/lymphoma virus type 1. Advances in Cancer Research. 89: 69-132. PMID 14587871 DOI: 10.1016/S0065-230X(03)01003-0  0.597
2002 Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J, Zermati Y, Mauviel A, Bazarbachi A, Hermine O. Human T-cell lymphotropic virus oncoprotein Tax represses TGF-β1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis Blood. 100: 4129-4138. PMID 12393612 DOI: 10.1182/Blood-2001-12-0372  0.479
2001 Mahieux R, Pise-Masison C, Gessain A, Brady JN, Olivier R, Perret E, Misteli T, Nicot C. Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood. 98: 3762-3769. PMID 11739184 DOI: 10.1182/Blood.V98.13.3762  0.511
2001 Nicot C, Mahieux R, Pise-Masison C, Brady J, Gessain A, Yamaoka S, Franchini G. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage. Molecular and Cellular Biology. 21: 7391-402. PMID 11585920 DOI: 10.1128/Mcb.21.21.7391-7402.2001  0.398
2001 Nicot C, Mulloy JC, Ferrari MG, Johnson JM, Fu K, Fukumoto R, Trovato R, Fullen J, Leonard WJ, Franchini G. HTLV-1 p12I protein enhances STAT5 activation and decreases the interleukin-2 requirement for proliferation of primary human peripheral blood mononuclear cells Blood. 98: 823-829. PMID 11468184 DOI: 10.1182/Blood.V98.3.823  0.508
2001 Johnson JM, Nicot C, Fullen J, Ciminale V, Casareto L, Mulloy JC, Jacobson S, Franchini G. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12I protein Journal of Virology. 75: 6086-6094. PMID 11390610 DOI: 10.1128/Jvi.75.13.6086-6094.2001  0.484
2000 Mahieux R, Pise-Masison CA, Lambert PF, Nicot C, De Marchis L, Gessain A, Green P, Hall W, Brady JN. Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function Journal of Virology. 74: 6866-6874. PMID 10888626 DOI: 10.1128/Jvi.74.15.6866-6874.2000  0.409
2000 Takemoto S, Trovato R, Cereseto A, Nicot C, Kislyakova T, Casareto L, Waldmann T, Torelli G, Franchini G. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14ARF-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells Blood. 95: 3939-3944. DOI: 10.1182/Blood.V95.12.3939.012K30_3939_3944  0.555
1999 Cereseto A, Kislyakova T, Parks RW, Nicot C, Franchini G. Differential response to genotoxic stress in immortalized or transformed human T-lymphotropic virus type I-infected T-cells. Journal of General Virology. 80: 1575-1581. PMID 10423124 DOI: 10.1099/0022-1317-80-7-1575  0.51
1999 Nicot C, Harrod R, Tang Y, Giam C. INTERACTION BETWEEN CBP/P300 AND HTLV-I TAX RESULTS IN DOWN-REGULATION OF BCL-2 EXPRESSION AND APOPTOSIS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 20: A33. DOI: 10.1097/00042560-199904010-00118  0.317
Show low-probability matches.